References

Cure Arthritis Naturally

Beat Arthritis Naturally

Get Instant Access

Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I (2004) Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 50:3580-3590 Benschop RJ, Cambier JC (1999) B cell development: signal transduction by antigen receptors and their surrogates. CurrOpin Immunol11:143-151 Boackle SA, Holers VM, Chen XJ, Szakonyi G, Karp DR, Wakeland EK, Morel L (2001) Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15:775-785 Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM (2001a) Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome. J Immunol 167:3610-3618 Bohnhorst JO, Thoen JE, Natvig JB, Thompson KM (2001b) Significantly depressed percentage of CD27+(memory) B cells among peripheral blood B cells in patients with primary Sjogren's syndrome. Scan J Immunol 54:421-427 Bohnhorst JO, Bjorgan MB, Thoen JE, Jonsson R, Natvig JB, Thompson KM (2002) Abnormal B cell differentiation in primary Sjogren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with serum IgG concentration. Clin Immunol 103:79-88 Bolland S, Ravetch JV (2000) Spontaneous autoimmune disease in Fc gamma RIIB-

deficient mice results from strain-specific epistasis. Immunity 13:277-285 Brezinschek HP, Brezinschek RI, Lipsky PE (1995a) Analysis of the heavy-chain repertoire of human peripheral B-cells using single-cell polymerase chain reaction. JImmunol 155:190-202 Brezinschek HP, Foster SJ, Brezinschek RI, Lipsky PE (1995b) The human-

immunoglobulin variable heavy-chain repertoire. Arthritis Rheum 38:1007 Brezinschek HP, Brezinschek RI, Foster SJ, Dörner T, Lipsky PE (1996) Analysis of the immunoglobulin repertoire ofhuman B-1 (CD5+) B cells. Arthritis Rheum 39:102 Cambridge G, Leandro MJ, Edwards JCW, Ehrenstein MR, Salden M, Webster D (2002) B lymphocyte depletion in patients with rheumatoid arthritis: serial studies of immunological parameters. Arthritis Rheum 46:S506 CambridgeG, Leandro MJ, Edwards JCW, Ehrenstein MR,SaldenM, Bodman-SmithM, Webster ADB (2003) Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 48:2146-2154 Cappione A, Anolik J, Pugh-Bernard A, Silverman G, Sanz I (2002) Human autoreactive VH4.34 B-cells are compartmentalized in the spleen marginal zone. Arthritis Rheum 46:S416

Carsetti R, Kohler G, Lamers MC (1995) Transitional B-cells are the target of negative selection in the B-cell compartment. J Exp Med 181:2129-2140 Chan OTM, Madaio MP, ShlomchikMJ (1999) The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 169:107-121

Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497-508

Corr M, Firestein GS (2002) Commentary—innate immunity as a hired gun: but is it rheumatoid arthritis? J Exp Med 195:F33-F35 Daeron M (1997) Fc receptor biology. Ann Rev Immunol 15:203-234 De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G (2002) Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis—evidence for a pathogenetic role of B cells. Arthritis Rheum 46:2029-2033 Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin JJ, Thomas ML, Fearon DT (1995) A role in B-cell activation for Cd22 and the protein-tyrosine-phosphatase Shp. Science 269:242-244 Dörner T, Burmester GR (2003) The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets. Curr Opin Rheumatol 15:246-252 Dörner T, Putterman C (2001) B cells, BAFF/zTNF4, TACl, and systemic lupus erythematosus. Arthritis Res 3:197-199 Dörner T, Foster SJ, Farner NL, Lipsky PE (1998) Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus. J Clin Invest 102:688-694 Edwards JC, Cambridge G, Leandro MJ (2000) Sustained improvement in rheumatoid arthritis following B lymphocyte depletion. Arthritis Rheum 43:S391 Edwards JCW, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Eng J Med 350:2572-2581 Firestein GS, Zvaifler NJ (2002) How important are T cells in chronic rheumatoid synovitis? II. T cell-independent mechanisms from beginning to end. Arthritis Rheum 46:298-308

Fujimoto M, Bradney AP, Poe JC, Steeber DA, Tedder TF (1999) Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity 11:191-200 Gaffney PM, Kearns GM, Shark KB, Ortmann WA, Selby SA, Malmgren ML, Rohlf KE, Ockenden TC, Messner RP, King RA, Rich SS, Behrens TW (1998) A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci U S A 95:14875-14879 Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R, Eibel H, Fischer B, Schaffer AA, Mages HW, Kroczek RA, Peter HH (2003) Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4:261-268 Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu WF, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404:995-999 Hansen A, Odendahl M, Reiter K, Jacobi A, Burmester GR, Lipsky PE, Dörner T (2002a) Disturbances in peripheral B cell subsets in patients with primary Sjogren's syndrome with a markedly diminished peripheral CD5+/CD27+ memory population. Arthritis Rheum 46:S597

Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, Burmester GR, Lipsky PE, Dörner T (2002b) Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 46:2160-2171 Hansen A, Gosemann M, Pruss A, Reiter K, Ruzickova S, Lipsky PE, Dörner T (2004) Abnormalities in peripheral B cell memory of patients with primary Sjogren's syndrome. Arthritis Rheum 50:1897-1908 HarleyJB, Moser KL, Gaffney PM, Behrens TW (1998) The genetics of human systemic lupus erythematosus. Curr Opin Immunol 10:690-696 Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F, Krystal G, Humphries RK (1998) Targeted disruption of SHIP leads to hemopoietic perturbations lung pathology, and a shortened life span. Genes Dev 12:1610-1620

Hirohata S, Ohshima N, Yanagida T, Aramaki K (2002) Regulation of human B cell function by sulfasalazine and its metabolites. Int Immunopharmacol 2:631-640 Huang SC, Jiang RH, Glas AM, Milner ECB (1996) Non-stochastic utilization of Ig V

region genes in unselected human peripheral B cells. Mol Immunol 33:553-560 Hutloff A , BuchnerK , ReiterK , BaeldeHJ , OdendahlM , JacobiA , DörnerT, Kroczek RA (2004) Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum 50:3211-3220

Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF (1997) CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 186:1923-1931 Isenberg DA, McClure C, Farewell V, Spellerberg M, Williams W, Cambridge G, Stevenson F (1998) Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 57:566-570 Iwai H, Abe M, Hirose S, Tsushima F, Tezuka K, Akiba H, Yagita H, Okumura K, Kohsaka H, Miyasaka N, Azuma M (2003) Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J Immunol 171:2848-2854 Jacobi A, Dörner T, Hansen A, Lipsky PE (1999) Identification of enhanced mutational activity and disturbed selection mechanisms on V-H gene rearrangements in systemic lupus erythematosus (SLE). Arthritis Rheum 42:S54 Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A, Valet G, Lipsky PE, Dörner T (2003) Correlation between circulating CD27 (high) plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 48:1332-1342

Kassahn D, Kolb C, Solomon S, Bochtler P, Illges H (2002) Few human autoimmune sera detect GPI. Nat Immunol 3:411-412 Kim HJ, Krenn V, Steinhauser G, Berek C (1999) Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J Immunol 162:3053-3062

Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kiku-tani H, Rajewsky K, Pasquali JL, Benoist C, Mathis D (1999) From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10:451-461

Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D (1996) Organ-

specific disease provoked by systemic autoimmunity. Cell 87:811-822 Kraj P, Rao SP, Glas AM, Hardy RR, Milner ECB, Silberstein LE (1997) The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells. J Immunol 158:5824-5832 Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S, Russell A, Dougados M, Emery P, Nuamah IF, Williams GR, Becker JC, Hagerty DT, More-land LW (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Eng J Med 349:1907-1915 Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, Fukazawa T, Jansen MD, Hashimoto H, van de Winkel JGJ, Kallenberg CGM, Tokunaga K (2002) Fc gamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus—contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46:1242-1254

Latour S, Fridman WH, Daeron M (1996) Identification, molecular cloning, biologic properties, and tissue distribution of a novel isoform of murine low-affinity IgG receptor homologous to human Fc gamma RIIB1. J Immunol 157:189-197 Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, MarshakRothstein A (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607 Leandro MJ, Edwards JCW, Cambridge G (2001) B lymphocyte depletion in rheumatoid arthritis. Early evidence for safety, efficacy, and dose response. Arthritis Rheum 44: S370

Leandro MJ, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA (2002a) An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum 46:2673-2677

Leandro MJ, Edwards JCW, Cambridge G (2002b) Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis 61:883-888

Leandro MJ, Ehrenstein MR, Edwards JCW, Manson J, Cambridge G, Isenberg DA (2003) Treatment of refractory lupus nephritis with B lymphocyte depletion. Arthritis Rheum 48:S378 Lioubin MN, Algate PA, Tsai S, Carlberg K, Aebersold R, Rohrschneider LR (1996) p150(Ship), a signal transduction molecule with inositol polyphosphates-phosphatase activity. Genes Dev 10:1084-1095 Looney RJ, Anolik J, Sanz I (2004a) B cells as therapeutic targets for rheumatic diseases.

Curr Opin Rheumatol 16:180-185 Looney RJ, Anolik J, Sanz I (2004b) B lymphocytes in systemic lupus erythematosus:

lessons from therapy targeting B cells. Lupus 13:381-390 Maccioni M, Zeder-Lutz G, Huang HC, Ebel C, Gerber P, Hergueux J, Marchal P, Duchatelle V, Degott C, van Regenmortel M, Benoist C, Mathis D (2002) Arthri-togenic monoclonal antibodies from K/BxN mice. J Exp Med 195:1071-1077 Mackay F, Browning JL (2002) BAFF: a fundamental survival factor for B cells. Nature

Rev Immunol 2:465-475 Mackay F, Mackay CR (2002) The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol 23:113-115

Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697-1710 Malbec O, Fridman WH, Daeron M (1999) Negative regulation of hematopoietic cell activation and proliferation by Fc gamma RIIB. Curr Top Microbiol Immunol 244:13-27

Mangialaio S, Ji H, Korganow AS, Kouskoff V, Benoist C, Mathis D (1999) The arthrito-genic T cell receptor and its ligand in a model of spontaneous arthritis. Arthritis Rheum 42:2517-2523

Maruyama M, Lam KP, Rajewsky K (2000) Memory B-cell persistence is independent of persisting immunizing antigen. Nature 407:636-642 Matsumoto I, Staub A, Benoist C, Mathis D (1999) Arthritis provoked by linked T and

B cell recognition of a glycolytic enzyme. Science 286:1732-1735 Mockridge CI, Chapman CJ, Spellerberg MB, Sheth B, Fleming TP, Isenberg DA, Stevenson FK (1998) Sequence analysis of V4-34-encoded antibodies from single B cells of two patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 114:129-136

Nishimura H, Honjo T (2001) PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 22:265-268 O'Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, Lin LL, Mantchev GT, Bram RJ, Noelle RJ (2004) BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 199:91-97 O'Keefe TL, Williams GT, Batista FD, Neuberger MS (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189:1307-1313 Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, Lipsky PE, Radbruch A, Dörner T (2000a) Disturbed peripheral B cellhemeostasis in SLE. Arthritis Rheum 43:S234

Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, Lipsky PE, Radbruch A, Dörner T (2000b) Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 165:5970-5979 Odendahl M, Keitzer R, Wahn U, Hiepe F, Radbruch A, Dörner T, Bunikowski R (2003) Perturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus. Ann Rheum Dis 62:851-858 Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A 98:13866-13871

Potter KN, Mockridge CI, Rahman A, Buchan S, Hamblin T, Davidson B, Isenberg DA, Stevenson FK (2002) Disturbances in peripheral blood B cell subpopulations in autoimmune patients. Lupus 11:872-877 Pritchard NR, Smith KGC (2003) B cell inhibitory receptors and autoimmunity. Immunology 108:263-273 Prodeus AP, Goerg S, Shen LM, Pozdnyakova OO, Chu L, Alicot EM, Goodnow CC, Carroll MC (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9:721-731

Pugh-Bernard AE, Silverman GJ, Cappione AJ, Villano ME, Ryan DH, Insel RA, Sanz I (2001) Regulation of inherently autoreactive VH4-34B cells in the maintenance ofhuman B cell tolerance. J Clin Invest 108:1061-1070 Rahman A, Latchman DS, Isenberg DA (1998) Immunoglobulin variable region sequences of human monoclonal anti-DNA antibodies. Semin Arthritis Rheum 28:141-154

Saito E, Fujimoto M, Hasegawa M, Komura K, Hamaguchi Y, Koburagi Y, Nagaoka T, Takehara K, Tedder TF, Sato S (2002) CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest 109:1453-1462 Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML (2001) An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111-2114 Schubert D, Schmidt M, Zaiss D, Jungblut PR, Kamradt T (2002) Autoantibodies to

GPI and creatine kinase in RA. Nature Immunol 3:411 Shai R , Quismorio FP, Li LL , Kwon OJ, Morrison J, Wallace DJ , Neuwelt CM , Brautbar C, Gauderman WJ, Jacob CO (1999) Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Human Mol Genet 8:639-644 Shlomchik MJ, Craft JE, Mamula MJ (2001) From T to B and back again: positive feedback in systemic autoimmune disease. Nature Rev Immunol 1:147-153 Shultz LD, Coman DR, Bailey CL, Beamer WG, Sidman CL (1984) Viable motheaten, a new allele at the motheaten locus .1. Pathology. Am J Pathol 116:179-192 Sidman CL, Shultz LD, Hardy RR, Hayakawa K, Herzenberg LA (1986) Production of immunoglobulin isotypes by Ly-1+ B cells in viable moth-eaten and normal mice. Science 232:1423-1425 Smith KGC, Fearon DT (2000) Receptor modulators of B-cell receptor signalling— CD19/CD22. Signal transduction and the coordination of B lymphocyte development and function I. Curr Top Microbiol Immunol 245:195-212 Smith KGC, Tarlinton DM, Doody GM, Hibbs ML, Fearon DT (1998) Inhibition of the

B cell by CD22: a requirement for Lyn. J Exp Med 187:807-811 Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW (1991) Enforced Bcl2 expression in B-lymphoid cells prolongs antibody-responses and elicits autoimmune-disease. Proc Natl Acad Sci U S A 88:8661-8665 Takahashi Y, Cerasoli DM, Dal Porto JM, Shimoda M, Freund R, Fang W, Telander DG, Malvey EN, Mueller DL, Behrens TW, Kelsoe G (1999) Relaxed negative selection in germinal centers and impaired affinity maturation in bcl-x(L) transgenic mice. J Exp Med 190:399-409 Tamir I, Dal Porto JM, Cambier JC (2000) Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction. CurrOpin Immunol 12:307-315

Tedder TF (1998) Introduction: response-regulators of B lymphocyte signaling thresholds provide a context for antigen receptor signal transduction. Semin Immunol 10:259-265

Tedder TF, Tuscano J, Sato S, Kehrl JH (1997) CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Ann Rev Immunol 15:481-504

Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL, Ambrose C (2001) BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293:2108-2111 Van Vollenhoven RF, Bieber MM, Powell MJ, Gupta PK, Bhat NM, Richards KL, Al-bano SA, Teng NNH (1999) VH4-34 encoded antibodies in systemic lupus ery-thematosus: a specific diagnostic marker that correlates with clinical disease characteristics. J Rheumatol 26:1727-1733 Von Bulow GU, van Deursen JM, Bram RJ (2001) Regulation of the T-independent humoral response by TACI. Immunity 14:573-582 Voswinkel J, Trumper L, Carbon G, Hopf T, Pfreundschuh M, Gause A (1996) Evidence for a selected humoral immune response encoded by V(H)4 family genes in the synovial membrane of a patient with rheumatoid arthritis (RA). Clin Exp Immunol 106:5-12

Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397-408 Xu SL, Lam KP (2001) B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol Cell Biol 21:4067-4074 Yan MH, Wang M, Chan B, Roose-Girma M, Erickson S, Baker T, Tumas D, Grewal IS, Dixit VM (2001) Activation and accumulation of B cells in TACI-deficient mice. Nature Immunol 2:638-643 Yavuz AS, Monson NL, Yavuz S, Grammer AC, Longo N, Girschick HJ, Lipsky PE (2002) Different patterns of bcl-6 and p53 gene mutations in tonsillar B cells indicate separate mutational mechanisms. Mol Immunol 39:485-493 Yi AK, Tuetken R, Redford T, Waldschmidt M, Kirsch J, Krieg AM (1998) CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol 160:4755-4761 Yu CCK, Tsui HW, Ngan BY, Shulman MJ, Wu GE, Tsui FWL (1996) B and T cells are not required for the viable motheaten phenotype. J Exp Med 183:371-380

CTMI (2006) 305:241-257 © Springer-Verlag Berlin Heidelberg 2006

Was this article helpful?

0 0
Treating Rheumatoid Arthritis With Herbs Spices Roots

Treating Rheumatoid Arthritis With Herbs Spices Roots

Did You Know That Herbs and Spices Have Been Used to Treat Rheumatoid Arthritis Successfully for Thousands of Years Do you suffer with rheumatoid arthritis Would you like to know which herbs and spices naturally reduce inflammation and pain 'Treating Rheumatoid Arthritis with Herbs, Spices and Roots' is a short report which shows you where to start.

Get My Free Ebook


Post a comment